Publikationen von 0000-0002-8333-7551
(ORCID: 0000-0002-8333-7551)

Koletzko, Leandra, Mahli, Abdo und Hellerbrand, Claus (2018) Development of an in vitro model to study hepatitis C virus effects on hepatocellular lipotoxicity and lipid metabolism. Pathology - Research and Practice 214 (10), S. 1700-1706. Volltext nicht vorhanden.

Mahli, Abdo , Koch, Andreas, Fresse, Kim, Schiergens, Tobias, Thasler, Wolfgang Erwin, Schönberger, Christina, Bergheim, Ina, Bosserhoff, Anja und Hellerbrand, Claus (2018) Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis. Laboratory Investigation 98 (12), S. 1614-1626. Volltext nicht vorhanden.

Sommer, Judith, Mahli, Abdo , Freese, Kim, Schiergens, Tobias S., Kuecuekoktay, Fulya Suzan, Teufel, Andreas, Thasler, Wolfgang E., Müller, Martina, Bosserhoff, Anja K. und Hellerbrand, Claus (2017) Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation <i>in vitro</i> and in mice. Oncotarget 8 (8). Volltext nicht vorhanden.

Mahli, Abdo , Saugspier, Michael, Koch, Andreas, Sommer, Judith, Dietrich, Peter, Lee, Seren , Thasler, Reinhard, Schulze-Luehrmann, Jan, Luehrmann, Anja, Thasler, Wolfgang Erwin, Müller, Martina, Bosserhoff, Anja und Hellerbrand, Claus (2017) ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis. Gut, gutjnl-2016-312485. Volltext nicht vorhanden.

Mahli, Abdo und Hellerbrand, Claus (2016) Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease. Digestive Diseases 34 Sup. 1, S. 32-39.

Mahli, Abdo , Thasler, Wolfgang E., Patsenker, Eleonora, Müller, Sebastian, Stickel, Felix, Müller, Martina, Seitz, Helmut K., Cederbaum, Arthur I. und Hellerbrand, Claus (2015) Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro. Oncotarget 6 (39), S. 41464-41478. Volltext nicht vorhanden.